Back to Trades
Rubin Jonathan
SVPChief Medical OfficerCIK 0001836067
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Rubin Jonathan, SVP, Chief Medical Officer, has disclosed $766.2K in transactions — all concentrated in SUPERNUS PHARMACEUTICALS, INC. (SUPN). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $0 |
| Feb 25 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Grant | $49.7K |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $677.7K |
| Sep 26 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Exercise | $38.8K |
| Sep 12 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | Award | $0 |
5 filings